CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to investigate the efficacy and safety of the lifileucel regimen in participants with previously treated endometrial...
Phase 2
Houston, Texas, United States and 6 other locations
study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent endometrial...
Phase 2
The Woodlands, Texas, United States and 13 other locations
and Femara (letrozole) can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will al...
Phase 2
Houston, Texas, United States and 1 other location
To learn if chemotherapy given in combination with radiation therapy, followed by maintenance therapy, can help to control endometrial cancer...
Phase 1
Houston, Texas, United States
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Shenandoah, Texas, United States and 65 other locations
To learn if the combination of DKN-01 and pembrolizumab can help to control advanced or recurrent endometrial cancer....
Phase 2
Houston, Texas, United States
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Conroe, Texas, United States and 210 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Houston, Texas, United States and 241 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Houston, Texas, United States and 202 other locations
The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...
Phase 3
Houston, Texas, United States and 161 other locations
Clinical trials
Research sites
Resources
Legal